Regenerative Medicine Market

Regenerative Medicine Market Study Offering Deep
Insight Related to Growth Trends During 2018-2026
Regenerative medicines are medical products or active pharmaceutical ingredients that have the
ability to cure or replace organs and tissues organs damaged by various factors such as aging,
diseases, trauma, and can also be used to provide stability in congenital disorders. According to
findings of various studies, regenerative medicines can also be useful in treating both chronic
and acute disorders in terms various context of abnormalities such as cardiovascular diseases,
dermal wounds, and in treatment of certain types of cancer. Furthermore, the current therapy
of organ and tissue transplantation for treating organ and tissue failures can result in patient
death due to limited or no donor supply and often result in severe complications in immune
system. Regenerative medicine helps alleviate such issues to a major extent.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/163
Players in the regenerative medicine market focus on fueling growth in the pharmaceutical
sector by adopting various strategies such as including the use of different materials in the
preparation that can offer better results and newly generated cells or with the combination of
both, in turn replacing the missing tissue and effectively serving its functions. The innate
healing response of the human body can also be favored to support the regenerating activities.
Age is a major factor that can affect the regeneration of the desired part, as the body’s ability
to regenerate is low among adults as compared to young population or lower vertebrates.
Materials play an important role in regeneration activities, as they form the basis of the growth
and replacement, as they can mimic the native extracellular matrix (ECM) of tissues.
Rising number of bone and joint surgeries to fuel the growth of regenerative medicine market
in the near future:
Rise in number of trauma case globally is expected to favor growth of the regenerative
medicine market in the near future. There are different types of prosthetics and implants that
are used to support the human body movement in case of trauma and severe injury. However,
a majority of the young population perceives these to be an eye sore and are increasingly
inclined towards non-obtrusive options that do not drastically alter their physical appearance
and activities. Regenerative medicine provides a viable alternative to such conventional methods
and also reduces risk of deformity. However, regenerative medicine is significantly expensive as
compared to conventional methods of treatment. Also, this treatment option is barely effective
for treatment of the geriatric population. These factors impede growth of the market to a
certain extent. According to University of California, Los Angeles (UCLA) Department of
Orthopedic Surgery, in 2015, around 7,515 orthopedic surgeries were conducted in the U.S. by
the department from July 2014 to June 2015. This number is expected to rise due to rise in
number of orthopedic trauma cases in the region, which is further projected to favor growth of
the regenerative medicine market in the near future.
Report includes chapters which deeply display the following deliverable about industry :
• Regenerative Medicine Market Research Objective and Assumption
• Regenerative Medicine Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Regenerative Medicine Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Regenerative Medicine Market, By Regions
• Regenerative Medicine Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Regenerative Medicine Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Regenerative Medicine Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Regenerative Medicine Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Major acquisitions to support growth of regenerative medicine market:
There are few recent acquisitions by the big brands in biotechnology that is expected to favor
growth of regenerative medicine industry. In August 2016, Medtronic Inc. acquired Heart Ware
International, Inc. — a provider of technologies for less-invasive, miniaturized, mechanical
circulatory support (MCS) for treatment of patients with advanced heart failure. This acquisition
is further expected to favor the working efficiency of the company and broadens its product
portfolio.
Competitor Analysis:
•
Depuy Synthes Inc.
•
Orthofix Inc.
•
NuVasive Inc.
•
Zimmer Holdings Inc.
Developed regions major growth engines of the regenerative medicine market:
Developed countries such as the U.S., Germany, U.K., France, and Japan have a highly
developed market for regenerative medicine, mainly due to technical advancements in the
region. According to Regenerative Medicine Annual Report, in 2013, in regenerative medicine
market there has been various product approvals along with annual revenue of around US$ 1
billion. Thus, this sector is expected to attract attention from investors and industry partners in
the near future. Furthermore, as per the report, around 60,000 stem cell transplants are
performed globally each year to treat various cancers and blood-based disorders. This augments
growth of the market of regenerative medicine. Also, as observed by Alliance for Regenerative
Medicine (ARM), in 2012, the bio-therapeutic companies distributing cell therapy products
generated around US$ 900 million, with 160,000 patients undergoing various related treatments.
Regenerative medicine market taxonomy:
By Technology
• Biomaterial
• Tissue Engineering
• Stem Cell Therapy
By Product Type
• Cell-based products
• Acellular products
By Application
• Orthopedic & Musculoskeletal Disorders
• Cardiology
• Dermatology
• Diabetes
• Central Nervous System Disorders
• Others
By Material
• Algae Derived Alginate
• Synthetic Polymer
• Poly-lactide-coglycolide
• poly-ethylene glycol
• Hydrogels
By Agent Type
• Biologics
• Autologous fibroblasts
• Hematopoietic stem and progenitor cells
• Cell-based medical devices
• Allogenic fibroblasts
• Cell extraction
• Biopharmaceuticals
• Tri-calcium Phosphate
• Osteogenic Protein
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs

Download Report